Oxford Finance Provides $125 Million Credit Facility to Kala Pharmaceuticals
Unicorn Nest news
Oxford Finance Provides $125 Million Credit Facility to Kala Pharmaceuticals
Oxford Finance LLC (“Oxford”), a leading specialty finance firm that provides senior debt to life sciences and healthcare services companies worldwide, has announced the closing of a $125 million senior secured term loan with Kala Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for diseases of the eye.
– Proceeds from the transaction will be used to refinance existing indebtedness and provide additional growth capital for the Kala’s marketing of its two approved ophthalmic products.